Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hier

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Head & Neck|August 7, 2019
Postoperative infection predicts poor survival in locoregionally advanced oral cancerMarco A Mascarella, Jayson Lee Azzi, Sabrina Daniela da Silva, et al.
Scientific Reports|May 12, 2021
Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapyJessica Hier, Olivia Vachon, Allison Bernstein, et al.
Nanomaterials (Basel, Switzerland)|October 2, 2020
Nanoparticle-Based Chemotherapy Formulations for Head and Neck Cancer: A Systematic Review and PerspectivesJefferson Muniz de Lima, Paulo Rogerio Bonan, Danyel Elias da Cruz Perez, et al.
Cancers|November 11, 2022
Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell CarcinomaLúcio Roberto Cançado Castellano, Sara Brito Silva Costa Cruz, Michael Hier, et al.
Clinical & Experimental Metastasis|August 22, 2025
Prognostic influence of chronic inflammation in patients with head and neck cancer based on sex differencesClaudia Antwi-Boasiako, Orr Dimitstein, Sophia Chehade, et al.
Psycho-Oncology|October 12, 2018
Contribution of psychiatric diagnoses to extent of opioid prescription in the first year post-head and neck cancer diagnosis: A longitudinal studyMelissa Henry, Ali Alias, Saul Frenkiel, et al.
Critical Reviews in Oncology/Hematology|March 13, 2024
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancerJenna Bouassaly, Naser Karimi, Luiz Paulo Kowalski, et al.
Biomedicines|January 26, 2024
Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell CarcinomaMai Atique, Isis Muniz, Fatemeh Farshadi, et al.
Head & Neck|December 25, 2008
Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomiaNaresh Jha, Hadi Seikaly, Jeffrey Harris, et al.
Cancer|October 24, 2013
TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic targetSabrina Daniela da Silva, Moulay A Alaoui-Jamali, Fernando Augusto Soares, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Head & Neck|August 7, 2019
Postoperative infection predicts poor survival in locoregionally advanced oral cancerMarco A Mascarella, Jayson Lee Azzi, Sabrina Daniela da Silva, et al.
Scientific Reports|May 12, 2021
Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapyJessica Hier, Olivia Vachon, Allison Bernstein, et al.
Nanomaterials (Basel, Switzerland)|October 2, 2020
Nanoparticle-Based Chemotherapy Formulations for Head and Neck Cancer: A Systematic Review and PerspectivesJefferson Muniz de Lima, Paulo Rogerio Bonan, Danyel Elias da Cruz Perez, et al.
Cancers|November 11, 2022
Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell CarcinomaLúcio Roberto Cançado Castellano, Sara Brito Silva Costa Cruz, Michael Hier, et al.
Clinical & Experimental Metastasis|August 22, 2025
Prognostic influence of chronic inflammation in patients with head and neck cancer based on sex differencesClaudia Antwi-Boasiako, Orr Dimitstein, Sophia Chehade, et al.
Psycho-Oncology|October 12, 2018
Contribution of psychiatric diagnoses to extent of opioid prescription in the first year post-head and neck cancer diagnosis: A longitudinal studyMelissa Henry, Ali Alias, Saul Frenkiel, et al.
Critical Reviews in Oncology/Hematology|March 13, 2024
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancerJenna Bouassaly, Naser Karimi, Luiz Paulo Kowalski, et al.
Biomedicines|January 26, 2024
Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell CarcinomaMai Atique, Isis Muniz, Fatemeh Farshadi, et al.
Head & Neck|December 25, 2008
Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomiaNaresh Jha, Hadi Seikaly, Jeffrey Harris, et al.
Cancer|October 24, 2013
TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic targetSabrina Daniela da Silva, Moulay A Alaoui-Jamali, Fernando Augusto Soares, et al.
Pageof 9